{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:15:04Z","timestamp":1761293704776,"version":"3.30.1"},"reference-count":12,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2018,9,14]]},"abstract":"<jats:p>FMS-like tyrosine kinase-3 fragments from exon 14 to the end without any mutations or deletions have been reported to fuse to ETV6 (TEL) in a few cases of myeloid\/lymphoid neoplasms with eosinophilia carrying a translocation t(12;13)(p13;q12). This fusion protein confers constitutive\n activation on the FLT3 fragment and induces factor-independent growth in transfected Ba\/F3 cells, indicating that it is an oncoprotein. However, the mechanism controlling the stability of this oncoprotein is unknown. In this study, we focus on finding factors controlling the stability of ETV6\/FLT3.\n We have shown that the stability of ETV6\/FLT3 is regulated by the Hsp90 chaperone. ETV6\/FLT3 fusion protein forms a complex with Hsp90 by coimmunoprecipitation analyses using an Hsp90 antibody. The association between ETV6\/FLT3 fusion protein and Hsp90 was impaired after treating ETV6\/FLT3\n transient transfection cos7 cells with 17-allylamino-17-demethoxygeldanamycin (17-AAG). 17-AAG induced a time- and dose-dependent downregulation of ectopically expressed ETV6\/FLT3 protein in cos7 and HeLa-transfected cells. By using cycloheximide to block new protein translation, we found\n that 17-AAG accelerated the decay of ETV6\/FLT3. Our findings could contribute to more understanding of the ETV6\/FLT3 regulation through Hsp90 chaperone and open the way to finding effective treatment strategies for this rare disease.<\/jats:p>","DOI":"10.3727\/096504018x15154104709325","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T01:13:01Z","timestamp":1519348381000},"page":"1201-1205","source":"Crossref","is-referenced-by-count":5,"title":["ETV6\/FLT3 Fusion Is a Novel Client Protein of Hsp90"],"prefix":"10.32604","volume":"26","author":[{"given":"Bui Thi Kim","family":"Ly","sequence":"first","affiliation":[{"name":"Department of Food Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Thanh","family":"Chi","sequence":"additional","affiliation":[{"name":"Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"issue":"9","key":"b1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"b2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2404266","article-title":"FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation","volume":"20","year":"2006","journal-title":"Leukemia"},{"issue":"8","key":"b3","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2011-03-343426","article-title":"Response of ETV6-FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3","volume":"118","year":"2011","journal-title":"Blood"},{"issue":"6","key":"b4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/leu.2012.333","article-title":"Direct binding of Grb2 has an important role in the development of myeloproliferative disease induced by ETV6\/FLT3","volume":"27","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"b5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00277-013-1843-9","article-title":"Successful allogeneic stem cell transplantation with long-term remission of ETV6\/FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia","volume":"93","year":"2014","journal-title":"Ann Hematol."},{"issue":"3","key":"b6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbrc.2009.03.157","article-title":"The juxtamembrane domain in ETV6\/FLT3 is critical for PIM-1 up-regulation and cell proliferation","volume":"383","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"issue":"10","key":"b7","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.leu.2401905","article-title":"Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation","volume":"14","year":"2000","journal-title":"Leukemia"},{"issue":"6","key":"b8","doi-asserted-by":"crossref","first-page":"e66378","DOI":"10.1371\/journal.pone.0066378","article-title":"Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"35","key":"b9","doi-asserted-by":"crossref","first-page":"30263","DOI":"10.1074\/jbc.M111.232348","article-title":"c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway","volume":"286","year":"2011","journal-title":"J Biol Chem."},{"issue":"5","key":"b10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","year":"2012","journal-title":"Cell"},{"issue":"12","key":"b11","first-page":"4483","article-title":"FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases","volume":"9","year":"2003","journal-title":"Clin Cancer Res."},{"issue":"8","key":"b12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/sj.leu.2402558","article-title":"Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors","volume":"16","year":"2002","journal-title":"Leukemia"}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20240527\/20240527162112_60028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:36:55Z","timestamp":1733521015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v26n8\/56735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,9,14]]}},"alternative-id":["0965-0407(20180914)26:8L.1201;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504018x15154104709325","relation":{},"ISSN":["0965-0407"],"issn-type":[{"type":"print","value":"0965-0407"}],"subject":[],"published":{"date-parts":[[2018,9,14]]}}}